EUR 8.06
(1.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.88 Million EUR | -3.25% |
2022 | 10.21 Million EUR | 1.74% |
2021 | 10.03 Million EUR | 61.12% |
2020 | 6.23 Million EUR | -18.59% |
2019 | 7.65 Million EUR | -20.78% |
2018 | 9.66 Million EUR | -12.51% |
2017 | 11.04 Million EUR | 6.01% |
2016 | 10.41 Million EUR | 13.15% |
2015 | 9.2 Million EUR | -34.21% |
2014 | 13.99 Million EUR | 359.2% |
2013 | 3.04 Million EUR | -23.1% |
2012 | 3.96 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 11.18 Million EUR | 0.0% |
2023 Q1 | 8.13 Million EUR | -20.34% |
2023 Q3 | 9.88 Million EUR | 21.46% |
2023 Q4 | 9.88 Million EUR | -0.0% |
2023 FY | 9.88 Million EUR | -3.25% |
2023 Q2 | 8.13 Million EUR | 0.0% |
2022 Q2 | 11.51 Million EUR | 0.0% |
2022 Q4 | 10.21 Million EUR | 0.0% |
2022 Q1 | 11.51 Million EUR | 14.65% |
2022 FY | 10.21 Million EUR | 1.74% |
2022 Q3 | 10.21 Million EUR | -11.26% |
2021 Q1 | 10.71 Million EUR | 71.91% |
2021 Q2 | 10.71 Million EUR | 0.0% |
2021 Q3 | 10.03 Million EUR | -6.28% |
2021 Q4 | 10.03 Million EUR | 0.0% |
2021 FY | 10.03 Million EUR | 61.12% |
2020 Q4 | 6.23 Million EUR | 0.0% |
2020 FY | 6.23 Million EUR | -18.59% |
2020 Q3 | 6.23 Million EUR | -16.28% |
2020 Q2 | 7.44 Million EUR | 0.0% |
2020 Q1 | 7.44 Million EUR | -2.76% |
2019 FY | 7.65 Million EUR | -20.78% |
2019 Q1 | 8.83 Million EUR | -8.53% |
2019 Q2 | 8.83 Million EUR | 0.0% |
2019 Q3 | 7.65 Million EUR | -13.39% |
2019 Q4 | 7.65 Million EUR | 0.0% |
2018 Q3 | 9.66 Million EUR | -23.24% |
2018 FY | 9.66 Million EUR | -12.51% |
2018 Q1 | 12.58 Million EUR | 13.98% |
2018 Q4 | 9.66 Million EUR | 0.0% |
2018 Q2 | 12.58 Million EUR | 0.0% |
2017 Q1 | 11.42 Million EUR | 9.66% |
2017 Q3 | 11.04 Million EUR | -3.33% |
2017 FY | 11.04 Million EUR | 6.01% |
2017 Q4 | 11.04 Million EUR | 0.0% |
2017 Q2 | 11.42 Million EUR | 0.0% |
2016 Q1 | 4.3 Million EUR | -53.29% |
2016 Q3 | 10.41 Million EUR | 142.22% |
2016 FY | 10.41 Million EUR | 13.15% |
2016 Q2 | 4.3 Million EUR | 0.0% |
2016 Q4 | 10.41 Million EUR | 0.0% |
2015 FY | 9.2 Million EUR | -34.21% |
2015 Q3 | 9.2 Million EUR | 9.47% |
2015 Q4 | 9.2 Million EUR | 0.0% |
2015 Q2 | 8.41 Million EUR | 0.0% |
2015 Q1 | 8.41 Million EUR | -39.9% |
2014 FY | 13.99 Million EUR | 359.2% |
2014 Q4 | 13.99 Million EUR | 0.0% |
2014 Q3 | 13.99 Million EUR | 213.23% |
2014 Q2 | 4.46 Million EUR | 46.48% |
2014 Q1 | 3.04 Million EUR | 0.08% |
2013 Q2 | 761.85 Thousand EUR | 0.0% |
2013 Q4 | 3.04 Million EUR | 0.0% |
2013 FY | 3.04 Million EUR | -23.1% |
2013 Q3 | 3.04 Million EUR | 300.0% |
2013 Q1 | 761.85 Thousand EUR | -23.1% |
2012 Q3 | 990.73 Thousand EUR | 0.0% |
2012 Q4 | 990.73 Thousand EUR | 0.0% |
2012 Q1 | 990.73 Thousand EUR | 0.0% |
2012 FY | 3.96 Million EUR | 0.0% |
2012 Q2 | 990.73 Thousand EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | 10.61 Million EUR | 6.877% |
Modulight Oyj | 63.96 Million EUR | 84.548% |
Revenio Group Oyj | 137.4 Million EUR | 92.807% |